Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pompe Pregnancy Sub-Registry
Sponsor: Genzyme, a Sanofi Company
Summary
This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the Pompe Registry, regardless of whether she is receiving disease-specific therapy (such as ERT with alglucosidase alfa or avalglucosidase alfa) and irrespective of the commercial product with which she may be treated. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of care treatment as determined by the patient's physician. The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Pompe disease during pregnancy, regardless of whether they receive disease-specific therapy, such as ERT with alglucosidase alfa or avalglucosidase alfa.
Official title: A Sub-registry to Observe the Effect of Alglucosidase Alfa or Avalglucosidase Alfa Treatment on Pregnancy and Infant Growth in Women With Pompe Disease
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2007-06-18
Completion Date
2034-01-31
Last Updated
2026-01-16
Healthy Volunteers
No
Conditions
Locations (26)
Barrow Neurol Group- Site Number : 840087
Phoenix, Arizona, United States
Emory University School Of Medicine- Site Number : 840060
Atlanta, Georgia, United States
Indianapolis University School of Medicine- Site Number : 840027
Indianapolis, Indiana, United States
Spectrum for Health- Site Number : 840019
Grand Rapids, Michigan, United States
New York University School Of Medicine- Site Number : 840040
New York, New York, United States
Mt. Sinai School of Medicine- Site Number : 840005
New York, New York, United States
Duke University Medical Center Genetics Dept- Site Number : 840037
Durham, North Carolina, United States
LSD Data Registry Site LLC- Site Number : 840094
Dublin, Ohio, United States
Oregon Health and Science University- Site Number : 840095
Portland, Oregon, United States
O&O Alpan, LLC- Site Number : 840025
Fairfax, Virginia, United States
Investigational Site Number : 056001
Ghent, Belgium
Investigational Site Number : 1910001
Zagreb, Croatia
Investigational Site Number : 1910002
Zagreb, Croatia
Investigational Site Number : 2030001
Prague, Czechia
Investigational Site Number : 380008
Brescia, Italy
Investigational Site Number : 380006
Cagliari, Italy
Investigational Site Number : 380005
Florence, Italy
Investigational Site Number : 380004
Genova, Italy
Investigational Site Number : 380013
Messina, Italy
Investigational Site Number : 380007
Milan, Italy
Investigational Site Number : 380009
Monza, Italy
Investigational Site Number : 380002
Padova, Italy
Investigational Site Number : 380011
Padua, Italy
Investigational Site Number : 380003
Pavia, Italy
Investigational Site Number : 380015
Roma, Italy
Investigational Site Number : 380012
Roma, Italy